Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Anxiety/Depression, Sleep and Alcohol in Elderly Anxiety/Depression, Sleep Disturbances and Alcohol Use Disorder in Elderly With Cognitive Complaints (MEM-ASA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04368416
Recruitment Status : Not yet recruiting
First Posted : April 29, 2020
Last Update Posted : July 20, 2020
Sponsor:
Information provided by (Responsible Party):
University Hospital, Caen

Brief Summary:

The goal of MEM-ASA is to investigate the prevalence of anxiety/depression, sleep disturbances and alcohol use disorder in elderly with cognitive complaints.

In memory clinics of Normandy (France), all patients aged over 50 year-old are systematically questioned about anxiety, depression, sleep quality and alcohol use disorder. They also perform a neuropsychological assessment. Questionnaires are given to the patient and his/her caregiver to be filled in at home.

Levels of anxiety/depression, sleep quality and alcohol consumption are related to neuropsychological performance, diagnosis and responses to the questionaires.


Condition or disease
Anxiety State Sleep Disturbance Alcohol Abuse Aging Dementia

Layout table for study information
Study Type : Observational
Estimated Enrollment : 3000 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Prevalence of Anxiety/Depression, Sleep Disturbances and Alcohol Use Disorder in Elderly With Cognitive Complaints
Estimated Study Start Date : October 1, 2020
Estimated Primary Completion Date : May 31, 2022
Estimated Study Completion Date : May 31, 2022

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Alcohol Anxiety




Primary Outcome Measures :
  1. Anxiety and depression [ Time Frame: At inclusion ]
    Responses to questions during anamnesis

  2. Sleep quality [ Time Frame: At inclusion ]
    Responses to questions during anamnesis

  3. Alcohol use disorder [ Time Frame: At inclusion ]
    Responses to questions during anamnesis



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   50 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patients of memory clinics in Normandy.
Criteria

Inclusion Criteria:

  • To have cognitive complaints
  • To have french as native language
  • Not to be opposed to be included
  • To be affiliated to the social security

Exclusion Criteria:

-To be under tutorship or curatorship


Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04368416


Contacts
Layout table for location contacts
Contact: Pierre BRANGER, MD 33231065548 branger-p@chu-caen.fr
Contact: Anne Lise PITEL, PhD 33231470125 anne-lise.pitel@unicaen.fr

Sponsors and Collaborators
University Hospital, Caen
Investigators
Layout table for investigator information
Principal Investigator: Pierre BRANGER, MD CHU CAEN
Layout table for additonal information
Responsible Party: University Hospital, Caen
ClinicalTrials.gov Identifier: NCT04368416    
Other Study ID Numbers: 2019-A02928-49
First Posted: April 29, 2020    Key Record Dates
Last Update Posted: July 20, 2020
Last Verified: April 2020
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Dyssomnias
Parasomnias
Alcoholism
Depression
Anxiety Disorders
Behavioral Symptoms
Mental Disorders
Nervous System Diseases
Alcohol-Related Disorders
Substance-Related Disorders
Chemically-Induced Disorders
Sleep Wake Disorders